10:45am (EST) Shares of Dendreon (DNDN, $11.03, up $3.43) were halted briefly after circuit breakers triggered on pending news. Shares have resumed trading after the company said sales of its prostate cancer drug, Provenge, more than tripled for the fourth quarter to $82 million compared to last year. The companyRead more
Dendreon (DNDN) Halted, Resumes Trading
MomentumOptionsTrading.com News Flash for 11/17/10
Dendreon (DNDN) Halted 10:30am (EST) Shares of Dendreon (DNDN, $35.87, no change) have been halted today due to pending news concerning its cancer drug, Provenge. Many of our subscribers know we have been following this company for years and we were one of the first believers of the company whenRead more
Dendreon (DNDN) HALTED, Akamai (AKAM) Aces Earnings
1:05pm (EST) The bulls are brushing off Tuesday’s debacle in a big way as they are carrying the market back to the highs prior to the Greece and Portugal news. The market is showing strong gains after better-than-expected earnings reports from a number of companies and after weekly U.S. jobless claimsRead more